About CANWELL BIOTECH
CANWELL BIOTECH is a company based in Guangzhou (China) founded in 2018.. CANWELL BIOTECH has raised $14.77 million across 1 funding round from investors including SDIC. CANWELL BIOTECH operates in a competitive market with competitors including Moderna, BeiGene, Incyte, Vir Biotechnology and MorphoSys, among others.
- Headquarter Guangzhou, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.77 M (USD)
in 1 rounds
-
Latest Funding Round
$14.77 M (USD), Series A
Aug 12, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CANWELL BIOTECH
CANWELL BIOTECH has successfully raised a total of $14.77M through 1 strategic funding round. The most recent funding activity was a Series A round of $14.77 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $14.8M
-
First Round
First Round
(12 Aug 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Series A - CANWELL BIOTECH | Valuation | SDIC |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CANWELL BIOTECH
CANWELL BIOTECH has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SDIC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment holding company
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CANWELL BIOTECH
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CANWELL BIOTECH
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Canwell Biotech Comparisons
Competitors of CANWELL BIOTECH
CANWELL BIOTECH operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, Vir Biotechnology and MorphoSys, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Novel anti-infectives for bacterial and fungal infections are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CANWELL BIOTECH
When was CANWELL BIOTECH founded?
CANWELL BIOTECH was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Where is CANWELL BIOTECH located?
CANWELL BIOTECH is headquartered in Guangzhou, China. It is registered at Guangzhou, Guangdong, China.
Who is the current CEO of CANWELL BIOTECH?
Henry Yu is the current CEO of CANWELL BIOTECH.
Is CANWELL BIOTECH a funded company?
CANWELL BIOTECH is a funded company, having raised a total of $14.77M across 1 funding round to date. The company's 1st funding round was a Series A of $14.77M, raised on Aug 12, 2022.
What does CANWELL BIOTECH do?
CANWELL BIOTECH was founded in 2018 in Guangzhou, China, within the biotechnology sector. Focus is placed on developing immunotherapies for cancer treatment. Operations center on advancing lead candidates such as CAN1012, a TLR7 agonist, and DPV-001, a dendritic cell-targeted vaccine designed to trigger innate and adaptive immune responses against tumor cells. Activities are conducted to support oncology research and therapeutic applications.
Who are the top competitors of CANWELL BIOTECH?
CANWELL BIOTECH's top competitors include Moderna, BeiGene and Regeneron Pharmaceuticals.
Who are CANWELL BIOTECH's investors?
CANWELL BIOTECH has 1 investor. Key investors include SDIC.